πŸ‡ΊπŸ‡Έ FDA
Patent

US 8043617

Human antibodies to human IL-6 receptor

granted A61KA61K2039/505A61P

Quick answer

US patent 8043617 (Human antibodies to human IL-6 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61P, A61P1/00, A61P1/04